The following article is a part of Ophthalmology Advisor’s conference coverage of the Southeastern Educational Congress of Optometry (SECO) 2021, held in Atlanta and virtually from April 28 to May 2, 2021. The team at Ophthalmology Advisor will be reporting on the presentations offered by these leading experts in optometry and ophthalmology. Check back for more from the SECO 2021 Meeting.
3-D printed eyewear. Daily wear contact lenses that treat allergic conjunctivitis. Eye drops for cataracts. Injectable liquid retinal prosthesis. These are just a few of the future advances in eye care covered at the Southeastern Educational Congress of Optometry (SECO) 2021 meeting held April 28 to May 2 in Atlanta.
During “Future in Focus: Emerging Eyecare Treatments and Technologies,” Chris Wroten, OD offered clinicians guidance on current and future therapeutics, especially those that combine pharmaceuticals with minimally invasive implants.
Therapies such as a bimatoprost ocular ring insert, once-a-day rho kinase inhibitor drops, and punctal plug delivery systems are making it easier for patients with glaucoma to become compliant with medical treatments.
In addition to pharmaceutical options, the presentation considered the use of specially designed goggles to balance intraocular and intracranial pressure, therapeutic ultrasound, and implants, among other new treatment options on the horizon.
The course also made space to discuss advancements in treatments outside of glaucoma, including acquired blepharoptosis, blepharitis, adenoviral conjunctivitis, bacterial-viral infections, keratitis, endophthalmitis, corneal ulcer, dry eye disease, age-related macular degeneration, diabetic retinopathy, diabetic macular edema, and Stargardt disease.
Dr Wroten even looked into technological updates to spectacles. While some manufacturers have electronically adaptive glasses in their pipelines (designed to adjust to a patient’s needs at the touch of a button), others are investing in various spectacle and contact lens designs that incorporate augmented reality to help control myopia before it progresses.
Both the medical and technological future of eye care is primed to completely redefine what ophthalmic treatments will look like in the coming years.
Disclosure: The presenter declared affiliations with the biotech, pharmaceutical, and/or device companies. Please see the original reference for a full list of authors’ disclosures.
Visit Ophthalmology Advisor’s conference section for complete coverage of the SECO 2021 Meeting and more.
Wroten C. Future in focus: emerging eyecare treatments & technologies. Presented at: Southeastern Educational Congress of Optometry (SECO) 2021 Annual Meeting; April 28-May 2, 2021; Atlanta, GA. Course 500.